Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Hypertension. 2012 Oct 29;60(6):1517–1523. doi: 10.1161/HYPERTENSIONAHA.112.203661

Table 1. Group subject characteristics.

Characteristic Fenofibrate Placebo
N (m/f) 12 (7/5) 10 (5/5)
Age, yr 63 ± 2 63 ± 2
Body mass index, kg/m2 24 ± 1 27 ± 1
Waist:Hip Ratio 0.84 ± 0.02 0.88 ± 0.03
SBP, mmHg 119 ± 3 122 ± 3
DBP, mmHg 76 ± 3 77 ± 1
Total cholesterol, mg/dl 207 ± 10 205 ± 9
LDL-C, mg/dl 128 ± 9 126 ± 5
HDL-C, mg/dl 57 ± 3 58 ± 8
Triglycerides, mg/dl 108 ± 10 105 ± 11
FBG, mg/dl 94 ± 2 92 ± 3

Data are mean±SE. SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; FBG, fasting blood glucose.